Valuation : Sanofi

Market Cap 92.55B 107B 86.78B 79.21B 149B 10,265B 150B 1,030B 402B 5,182B 403B 394B 17,182B P/E 2026 *
12.3x
P/E 2027 * 10.7x
Enterprise Value 104B 121B 97.52B 89.02B 168B 11,536B 168B 1,157B 451B 5,823B 453B 443B 19,309B EV / Sales 2026 *
2.19x
EV / Sales 2027 * 1.99x
Free-Float
88.34%
Yield 2026 *
5.51%
Yield 2027 * 5.82%
1 day-0.03%
1 week-2.08%
Current month+4.26%
1 month-2.85%
3 months+1.55%
6 months-5.91%
Current year-6.89%
1 week 76.9
Extreme 76.9
79.18
1 month 72.1
Extreme 72.1
79.18
Current year 71.27
Extreme 71.27
84.9
1 year 71.27
Extreme 71.27
90.78
3 years 71.27
Extreme 71.27
111
5 years 71.27
Extreme 71.27
111
10 years 63.15
Extreme 63.15
111
Manager TitleAgeSince
Chief Executive Officer 65 01/05/2026
Director of Finance/CFO 64 01/04/2024
Chief Tech/Sci/R&D Officer 51 11/09/2023
Director TitleAgeSince
Director/Board Member 60 30/04/2019
Director/Board Member 57 28/04/2020
Director/Board Member 65 28/04/2020
Change 5-day change 1-year change 3-year change Capi.($)
-0.03%-2.08% - - 107B
-0.13%-6.44%+60.47%+112.05% 1,047B
+0.85%-0.81%+52.77%+63.15% 646B
-1.03%-3.58%+22.87%+73.29% 451B
-1.46%-4.50%+37.43%+38.41% 355B
-0.72%-2.89%+21.86%+36.79% 291B
-1.19%-2.21%+1.35%+12.29% 252B
-1.05%-1.57%+51.40%+68.55% 234B
+0.08%-1.78%-17.64%-54.29% 203B
-2.14%-0.30%+29.42%+89.10% 181B
Average -0.69%-2.68%+28.88%+48.82% 406.59B
Weighted average by Cap. -0.47%-3.46%+38.66%+65.51%

Financials

2026 *2027 *
Net sales 47.59B 55.23B 44.62B 40.73B 76.74B 5,279B 76.98B 529B 207B 2,665B 207B 203B 8,835B 50.7B 58.83B 47.53B 43.39B 81.74B 5,623B 82B 564B 220B 2,838B 221B 216B 9,412B
Net income 7.91B 9.18B 7.42B 6.77B 12.76B 877B 12.8B 88B 34.33B 443B 34.47B 33.72B 1,469B 9.24B 10.73B 8.67B 7.91B 14.9B 1,025B 14.95B 103B 40.12B 518B 40.28B 39.4B 1,716B
Net Debt 11.46B 13.3B 10.74B 9.81B 18.47B 1,271B 18.53B 127B 49.73B 641B 49.92B 48.83B 2,127B 8.3B 9.64B 7.79B 7.11B 13.39B 921B 13.43B 92.37B 36.04B 465B 36.18B 35.39B 1,542B
Logo Sanofi
Sanofi is the largest European pharmaceutical group. Net sales by family of products break down as follows: - pharmaceutical products (81.8%): prescription drugs for the treatment of multiple sclerosis, neurological diseases, inflammatory diseases, autoimmune diseases, rare diseases, cancers and rare hematological diseases; - human vaccines (18.2%): pediatric vaccines, vaccines for flu, meningitis, and polio, booster vaccines, and vaccines for travelers and endemic areas. At the end of 2025, the group had 37 production sites worldwide. Net sales are distributed geographically as follows: France (3.9%), Europe (17.1%), the United States (50.8%), China (6%) and other (22.2%).
Employees
74,846
Date Price Change Volume
28/08/26 €77.32 -0.03% 758
27/08/26 €77.34 -1.20% 1,491
26/08/26 €78.28 -0.63% 1,096
25/08/26 €78.78 +0.60% 1,770
24/08/26 €78.31 -0.82% 1,195
Trader
Investor
Global
Quality
ESG MSCI
AA
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
24
Last Close Price
77.25EUR
Average target price
94.28EUR
Spread / Average Target
+22.04%

Quarterly revenue - Rate of surprise